Meet the Team

Dr. Lin has over 20 years of life sciences and technology industry experience. He spent significant time at Plexxikon, where most recently he served as Chief Operating Officer. He joined Plexxikon in 2005 and held positions of increasing responsibility in business development and operations management. Dr. Lin led much of the IND filing effort for vemurafenib/Zelboraf® and was a principal contributor to the drug’s early development. He was part of Plexxikon’s deal team responsible for three licensing deals valued collectively at over $2 billion. Prior to Plexxikon, Dr. Lin was an assistant to the CEO of Dendreon Corporation and served as a consultant to multiple pharmaceutical, biotech and medical device companies including Medtronic, Othera Pharmaceuticals and Acuity Pharmaceuticals. Dr. Lin was also formerly Vice President of Business Development for eTechtransfer, a biotechnology licensing and marketplace start-up that he co-founded. Previously, Dr. Lin was an operations engineer managing large scale manufacturing operations across multiple industries for BASF AG and Shell Oil Company. Dr. Lin received dual M.D. and M.B.A. degrees from the University of Pennsylvania School of Medicine and the Wharton School of Business. Before graduate school, he earned a B.S.E. in Chemical Engineering from the University of Michigan – Ann Arbor, where he graduated summa cum laude.

Fiona has trained extensively as a bench scientist, working on Neuroscience, Skin Biology, Stem cells and Oncology projects in academic and industry institutions across the world. Her scientific work has contributed to the foundations of new biotech start-ups as well as acquisition of competitive local and international research grants. Beyond her technical training, she has always been keen on extending the translatability of lab findings into real world solutions. At NSG, Fiona functions as an Investment Associate to assist in performing due diligence on new deals and formulation of investment memos.

Fiona was a recipient of the National Science Scholarship (NSS) from Agency of Science Technology and Research (A*STAR), Singapore. She received her DPhil from University of Oxford and her bachelor’s from Imperial College London (First Class Honours). After completing her studies, she underwent postdoctoral training at Karolinska Institutet (Sweden), Genome Institute of Singapore (A*STAR) and National Cancer Centre Singapore (NCCS).